BioVie Inc.
Formulations of Terlipressin
Last updated:
Abstract:
The disclosure provides pharmaceutical compositions comprising terlipressin having increased concentration with long term storage stability.
Status:
Application
Type:
Utility
Filling date:
18 Mar 2022
Issue date:
30 Jun 2022